<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T01:56:56Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/17976" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/17976</identifier><datestamp>2026-10-18T20:56:17Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Platelet Activity Increases in Patients with Diabetic Retinopathy</dc:title><dc:creator>Mertoglu, Cuma</dc:creator><dc:creator>Ozcicek, Adalet</dc:creator><dc:creator>ÇOBAN, T. Abdulkadir</dc:creator><dc:creator>karakurt, yucel</dc:creator><dc:creator>ŞİRANLI, GÜLŞAH</dc:creator><dc:creator>Ersoy, Alevtina</dc:creator><dc:subject>Genel ve Dahili Tıp</dc:subject><dc:subject>Hematoloji</dc:subject><dc:subject>Onkoloji</dc:subject><dc:subject>Sağlık Bilimleri ve Hizmetleri</dc:subject><dc:description>Objective: The role of new inflammatory markers such as  neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, mean  platelet volume, and platelet distribution width in diabetic  microvascular complications was investigated. Methods: A total of 266 (172 female, 94 male) individuals  were divided into 5 groups: group 1, who have diabetes without  any complications for at least 10 years; group 2, only diabetic  nephropathy; group 3, only diabetic neuropathy; group 4, only  diabetic retinopathy; and group 5, control group. Results: Glucose and HbA1c were higher in retinopathy, neuropa thy, and nephropathy groups than in the control group (P &lt; .001).  Neutrophil-lymphocyte ratio in the neuropathy group was higher  in the retinopathy and uncomplicated diabetic groups (mean ±  SD; 2.4 ± 2.9, 1.6 ± 0.5, 1.5 ± 0.5, P = .018, P = .001, respectively),  and platelet-lymphocyte ratio was higher only in the retinopa thy group (mean ± SD; 133.8 ± 59, 105.5 ± 34, P = .001). In the  retinopathy group, mean platelet volume and platelet distribution  width were higher than the control group and the uncomplicated  diabetic group (mean platelet volume mean ± SD; 10.6 ± 1.0, 10.0  ± 0.6, 9.7 ± 1.9, P = .009, P = .003, platelet distribution width mean  ± SD; 13.0 ± 2.3, 11.4 ± 1.2, 11.7 ± 1.6, P &lt; .001, P = .003, respec tively). Conclusions: Patients with diabetic neuropathy have sub clinical inflammation, and patients with retinopathy have platelet  activation. However, further studies are needed to investigate the  mechanism of this increased inflammation and platelet reactivity  in the development of these complications.</dc:description><dc:date>2022</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/17976</dc:identifier><dc:identifier>https://doi.org/10.5152/abcr.2022.21020</dc:identifier><dc:identifier>2687-4520</dc:identifier><dc:language>en</dc:language><dc:relation>Archives of Basic and Clinical Research</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/17976</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>